Further investigation into the molecular mechanism underlying dysregulation of MALAT1 expression in OSCC cells will help to better understand tumor progression of OSCC, identify candidate biomarkers for OSCC prognosis, and guide the development of therapeutic targets for oral cancer. This evidence concerns the gene MALAT1 and lip and oral cavity carcinoma.